BioAtla

-$0.62 (-2.19%) Today
$0.00 (0.00%) As of 8:14 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioAtla and other ETFs, options, and stocks.

About BCAB

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021.

CEO
Jay M. Short
Employees
—
Headquarters
San Diego, California
Founded
2007

BCAB Key Statistics

Market Cap
937.48M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
138.74K
High Today
$28.44
Low Today
$27.50
Open Price
$28.07
Volume
118.62K
52 Week High
$76.63
52 Week Low
$25.62

BCAB Earnings

-$1.50
-$1.00
-$0.50
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure